Meningococcal vaccination for children with sickle cell disease: which statement is true?

Study for the Burns Pediatric Test. Access flashcards and multiple choice questions with detailed explanations. Excel in your pediatric examination!

Multiple Choice

Meningococcal vaccination for children with sickle cell disease: which statement is true?

Explanation:
Children with sickle cell disease have functional asplenia, which makes them particularly vulnerable to invasive meningococcal disease. To protect them, meningococcal conjugate vaccination is recommended starting at age 2 years and then boosted every 5 years if the risk persists. This schedule provides ongoing protection through childhood and adolescence, when exposure risk remains significant. The vaccine does not increase the risk of sepsis; it reduces the risk by preventing meningococcal infection. The other statements misstate when vaccination can start, who should receive it, or its effect on sepsis risk.

Children with sickle cell disease have functional asplenia, which makes them particularly vulnerable to invasive meningococcal disease. To protect them, meningococcal conjugate vaccination is recommended starting at age 2 years and then boosted every 5 years if the risk persists. This schedule provides ongoing protection through childhood and adolescence, when exposure risk remains significant. The vaccine does not increase the risk of sepsis; it reduces the risk by preventing meningococcal infection. The other statements misstate when vaccination can start, who should receive it, or its effect on sepsis risk.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy